Durable Response to Tyrosine Kinase Inhibitor Therapy in a Lung Cancer Patient Harboring Epidermal Growth Factor Receptor Tandem Kinase Domain Duplication

J Thorac Oncol. 2015 Oct;10(10):e97-9. doi: 10.1097/JTO.0000000000000586.

Authors

Christina S Baik¹, David Wu, Christina Smith, Renato G Martins, Colin C Pritchard

Affiliation

¹ *Department of Medicine, University of Washington, Seattle, Washington; and †Department of Laboratory Medicine, University of Washington, Seattle.

PMID: 26398831
DOI: 10.1097/JTO.0000000000000586

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Non-Small-Cell Lung / drug therapy*
ErbB Receptors / antagonists & inhibitors*
ErbB Receptors / metabolism
Female
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / enzymology
Middle Aged
Protein Kinase Inhibitors / therapeutic use*
Protein Structure, Tertiary

Substances

Protein Kinase Inhibitors
EGFR protein, human
ErbB Receptors